BIM
AMRX icon

Bogle Investment Management’s Amneal Pharmaceuticals AMRX Stock Holding History

Bogle Investment Management’s Portfolio AMRX Stock Details AMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-60,900
Closed -$236K – 152
2020
Q3 		$236K Buy
60,900
+2,400
+4% +$10.3K 0.07% 217
2020
Q2 		$278K Buy
+58,500
New +$241K 0.05% 264

Other funds holding AMRX

TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Prudential Financial
Prudential Financial Newark, New Jersey $81.2B AUM 27.81% 1-Year Est. Return

Bogle Investment Management's AMRX Position: Q4 2020 in Review

Bogle Investment Management sold out of Amneal Pharmaceuticals (AMRX) in Q4 2020, closing a stake of 60,900 shares — an estimated $236K sold.

Bogle Investment Management first reported a position in AMRX in Q2 2020 and held it in 2 quarters. The position peaked at $278K in Q2 2020. 133 funds tracked by Wall St. Rank hold AMRX as of Q4 2020.

  • Bogle Investment Management reported no remaining Amneal Pharmaceuticals position as of Q4 2020 after selling out during the quarter.
  • Bogle Investment Management sold 60,900 Amneal Pharmaceuticals shares in Q4 2020, an estimated $236K.
  • Bogle Investment Management first reported a position in Amneal Pharmaceuticals in Q2 2020 and held it in 2 quarters.
  • Bogle Investment Management's Amneal Pharmaceuticals position peaked at $278K in Q2 2020.
  • 133 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q4 2020.

Based on Bogle Investment Management's 13F filing for Q4 2020, filed 12 Feb 2021.